Cargando…

Characteristics and predictors of off‐label use of antipsychotics in general population sample

OBJECTIVE: Increasing number of people have been prescribed antipsychotics (APs) off‐label in recent decades. This study aimed to identify the characteristics and predictors of receiving prescription of antipsychotics off‐label. METHODS: The study sample was part of the Northern Finland Birth Cohort...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pirhonen, Eero, Haapea, Marianne, Rautio, Nina, Nordström, Tanja, Turpeinen, Miia, Laatikainen, Outi, Koponen, Hannu, Silvan, Jenni, Miettunen, Jouko, Jääskeläinen, Erika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543108/ https://www.ncbi.nlm.nih.gov/pubmed/35781871 http://dx.doi.org/10.1111/acps.13472

Ejemplares similares

Off-label prescribing of antipsychotics: prescribing practices and clinical experiences of Finnish physicians
por: Rautio, N., et al.
Publicado: (2022)

T78. LONG-TERM PROGNOSIS OF SCHIZOPHRENIA - RESULTS FROM THE NORTHERN FINLAND BIRTH COHORT 1966
por: Jääskeläinen, Erika, et al.
Publicado: (2018)

Employment trajectories until midlife in schizophrenia and other psychoses: the Northern Finland Birth Cohort 1966
por: Majuri, Tuomas, et al.
Publicado: (2022)

Lifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort
por: Husa, Anja P., et al.
Publicado: (2017)

Twenty Years of Schizophrenia Research in the Northern Finland Birth Cohort 1966: A Systematic Review
por: Jääskeläinen, Erika, et al.
Publicado: (2015)

Psychiatric research in the Northern Finland Birth Cohort 1986 – a systematic review
por: Miettunen, Jouko, et al.
Publicado: (2019)

T136. DO VITAMIN D SUPPLEMENTATION DURING THE FIRST YEAR OF LIFE PREDICT COGNITION IN PSYCHOSES DURING MIDLIFE?
por: Seppälä, Jussi, et al.
Publicado: (2018)

The Risks and Outcomes Resulting From Medication Errors Reported in the Finnish Tertiary Care Units:: A Cross-Sectional Retrospective Register Study
por: Laatikainen, Outi, et al.
Publicado: (2020)

Early environmental factors and somatic comorbidity in schizophrenia and nonschizophrenic psychoses: A 50-year follow-up of the Northern Finland Birth Cohort 1966
por: Korpela, Hanna, et al.
Publicado: (2020)

Prevalence and characteristics of psychiatric morbidity treated in specialized health care in a nationwide cohort of people with newly diagnosed Alzheimer's disease
por: Alastalo, Aleksi, et al.
Publicado: (2022)

Longitudinal regional brain volume loss in schizophrenia: Relationship to antipsychotic medication and change in social function
por: Guo, Joyce Y., et al.
Publicado: (2015)

M131. RETURN TO LABOUR MARKET IN SCHIZOPHRENIA AND OTHER PSYCHOSES – THE NORTHERN FINLAND BIRTH COHORT 1966
por: Majuri, Tuomas, et al.
Publicado: (2020)

Early childhood and adolescent risk factors for psychotic depression in a general population birth cohort sample
por: Nietola, Miika, et al.
Publicado: (2020)

S230. LONG-TERM ANTIPSYCHOTIC MEDICATION IN SCHIZOPHRENIA: BENEFITS, RISKS AND FOLLOW-UP: DATA FROM FINNISH COHORT STUDIES AND SYSTEMATIC REVIEW
por: Isohanni, Matti, et al.
Publicado: (2018)

Longitudinal Changes in Total Brain Volume in Schizophrenia: Relation to Symptom Severity, Cognition and Antipsychotic Medication
por: Veijola, Juha, et al.
Publicado: (2014)

Investigating errors in medical imaging: medical malpractice cases in Finland
por: Tarkiainen, Tarja, et al.
Publicado: (2021)

Detecting Patient Safety Errors by Characterizing Incidents Reported by Medical Imaging Staff
por: Tarkiainen, Tarja, et al.
Publicado: (2022)

Linking the Developmental and Degenerative Theories of Schizophrenia: Association Between Infant Development and Adult Cognitive Decline
por: Kobayashi, Hiroyuki, et al.
Publicado: (2014)

Hospitalizations Due to Adverse Drug Events in the Elderly—A Retrospective Register Study
por: Laatikainen, Outi, et al.
Publicado: (2016)

Editorial: Have We Got Better in Making Our Schizophrenia Patients Better?
por: Jääskeläinen, Erika, et al.
Publicado: (2020)

Aberrant Functional Connectivity in the Default Mode and Central Executive Networks in Subjects with Schizophrenia – A Whole-Brain Resting-State ICA Study
por: Littow, Harri, et al.
Publicado: (2015)

Age at onset and the outcomes of schizophrenia: A systematic review and meta‐analysis
por: Immonen, Johanna, et al.
Publicado: (2017)

Antipsychotics in off-label use: prescription practices, benefits and risks Results from APSY Oulu study
por: Jääskeläinen, E.
Publicado: (2023)

F128. THE AGE OF ONSET OF SCHIZOPHRENIA SPECTRUM DISORDERS
por: Miettunen, Jouko, et al.
Publicado: (2018)

Poor premorbid school performance, but not severity of illness, predicts cognitive decline in schizophrenia in midlife
por: Rannikko, Irina, et al.
Publicado: (2015)

T157. THE COURSE OF SCHIZOPHRENIA-RELATED NEURAL FINGERPRINTS OVER NINE YEARS - A LONGITUDINAL POPULATION-BASED MACHINE LEARNING STUDY
por: Lieslehto, Johannes, et al.
Publicado: (2020)

Temperament and longitudinal changes in physical activity – the Northern Finland Birth Cohort 1966 Study
por: Karppanen, Anna-Kaisa, et al.
Publicado: (2023)

Serum C-reactive protein in adolescence and risk of schizophrenia in adulthood: A prospective birth cohort study
por: Metcalf, Stephen A., et al.
Publicado: (2017)

The progression of disorder-specific brain pattern expression in schizophrenia over 9 years
por: Lieslehto, Johannes, et al.
Publicado: (2021)

Different vulnerability indicators for psychosis and their neuropsychological characteristics in the Northern Finland 1986 Birth Cohor
por: Mukkala, Sari, et al.
Publicado: (2011)

Antipsychotic Use and Mortality in Persons with Alcohol-Related Dementia or Wernicke–Korsakoff Syndrome: A Nationwide Register Study in Finland
por: Palm, Anniina, et al.
Publicado: (2023)

An audit into the monitoring of off-label antipsychotics in primary care
por: Rafi, Damir, et al.
Publicado: (2021)

Off-label use of atypical antipsychotics- Where are we?
por: Vaz, R. P., et al.
Publicado: (2023)

Metabolism of Oxycodone in Human Hepatocytes from Different Age Groups and Prediction of Hepatic Plasma Clearance
por: Korjamo, Timo, et al.
Publicado: (2012)

Medication-related adverse events in health care—what have we learned? A narrative overview of the current knowledge
por: Laatikainen, O., et al.
Publicado: (2021)

Off-label indications for atypical antipsychotics: A systematic review
por: Fountoulakis, Konstantinos N, et al.
Publicado: (2004)

Off-Label Antipsychotic Prescribing for Persons With Dementia in Assisted Living
por: Wretman, Christopher, et al.
Publicado: (2020)

Early Motor Developmental Milestones and Schizotypy in the Northern Finland Birth Cohort Study 1966
por: Filatova, Svetlana, et al.
Publicado: (2018)

Association between developmental milestones and age of schizophrenia onset: Results from the Northern Finland Birth Cohort 1966
por: Stochl, Jan, et al.
Publicado: (2019)

Which anthropometric measures best indicate type 2 diabetes among Russian, Somali and Kurdish origin migrants in Finland? A cross-sectional study
por: Skogberg, Natalia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_diiep6n2e65b7g1ksst0arhra7